Compare WLTH & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WLTH | STAA |
|---|---|---|
| Founded | 2008 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2025 | 1995 |
| Metric | WLTH | STAA |
|---|---|---|
| Price | $9.16 | $23.03 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | $12.86 | ★ $22.81 |
| AVG Volume (30 Days) | 884.4K | ★ 952.0K |
| Earning Date | 05-18-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.07 | ★ 0.26 |
| Revenue | ★ $364,993,000.00 | $239,442,000.00 |
| Revenue This Year | $10.58 | $30.82 |
| Revenue Next Year | $23.43 | $8.41 |
| P/E Ratio | $129.71 | ★ $94.85 |
| Revenue Growth | ★ 18.17 | N/A |
| 52 Week Low | $7.20 | $15.59 |
| 52 Week High | $14.12 | $35.87 |
| Indicator | WLTH | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 45.53 | 39.58 |
| Support Level | $8.65 | $22.91 |
| Resistance Level | $9.32 | $25.31 |
| Average True Range (ATR) | 0.30 | 1.44 |
| MACD | -0.05 | 0.09 |
| Stochastic Oscillator | 27.64 | 20.77 |
Wealthfront Corp is a product-driven technology company that built a financial solutions platform for digital natives. The platform is designed to address the needs of the wealth builders within these generations. Its business model is designed to optimize for clients' success. The focus on delivering fully automated services results in being one of the lowest cost producers in each category in which participate. The group generates revenue from cash management and investment advisory products. Cash management revenue is earned from fees received for the delivery of cash management services, including the cash sweep program.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.